InChI=1S/C84H150N4O34/c1- 6- 8- 10- 12- 14- 16- 18- 20- 21- 22- 23- 24- 25- 26- 27- 29- 31- 33- 35- 37- 39- 41- 62(101) 88- 53(54(97) 40- 38- 36- 34- 32- 30- 28- 19- 17- 15- 13- 11- 9- 7- 2) 49- 113- 79- 71(107) 70(106) 73(60(47- 92) 115- 79) 117- 80- 72(108) 77(74(61(48- 93) 116- 80) 118- 78- 65(87- 52(5) 96) 69(105) 67(103) 58(45- 90) 114- 78) 122- 84(82(111) 112) 43- 56(99) 64(86- 51(4) 95) 76(121- 84) 68(104) 59(46- 91) 119- 83(81(109) 110) 42- 55(98) 63(85- 50(3) 94) 75(120- 83) 66(102) 57(100) 44- 89/h38,40,53- 61,63- 80,89- 93,97- 100,102- 108H,6- 37,39,41- 49H2,1- 5H3,(H,85,94) (H,86,95) (H,87,96) (H,88,101) (H,109,110) (H,111,112) /b40- 38+/t53- ,54+,55- ,56- ,57+,58+,59+,60+,61+,63+,64+,65+,66+,67- ,68+,69+,70+,71+,72+,73+,74- ,75?,76?,77+,78- ,79+,80- ,83+,84- /m0/s1 |
QQMRPVREOTZDMG-AKMGTXFXSA-N |
[C@@H] 1([C@@H] ([C@H] ([C@@H] ([C@H] (O1) CO) O[C@H] 2[C@@H] ([C@H] ([C@H] ([C@H] (O2) CO) O[C@H] 3[C@@H] ([C@H] ([C@H] ([C@H] (O3) CO) O) O) NC(=O) C) O[C@@] 4(C[C@@H] ([C@H] (C(O4) [C@@H] ([C@@H] (CO) O[C@@] 5(C[C@@H] ([C@H] (C(O5) [C@@H] ([C@@H] (CO) O) O) NC(=O) C) O) C(=O) O) O) NC(=O) C) O) C(=O) O) O) O) O) OC[C@@H] ([C@@H] (/C=C/CCCCCCCCCCCCC) O) NC(=O) CCCCCCCCCCCCCCCCCCCCCCC |
|
(2S,4S,5R)- 6- [(1S,2R)- 2- {[(2S,4S,5R)- 2- carboxy- 5- acetamido- 4- hydroxy- 6- [(1R,2R)- 1,2,3- trihydroxypropyl]oxan- 2- yl]oxy}- 1,3- dihydroxypropyl]- 2- {[(2S,3R,4R,5S,6R)- 2- {[(2R,3S,4R,5R,6R)- 4,5- dihydroxy- 6- {[(2S,3R,4E)- 3- hydroxy- 2- tetracosanamidooctadec- 4- en- 1- yl]oxy}- 2- (hydroxymethyl)oxan- 3- yl]oxy}- 5- {[(2S,3R,4R,5R,6R)- 3- acetamido- 4,5- dihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxy}- 3- hydroxy- 6- (hydroxymethyl)oxan- 4- yl]oxy}- 5- acetamido- 4- hydroxyoxane- 2- carboxylic acid
|
HMDB
|
GalNAc-beta1->4(NeuAc-alpha2->8NeuAc2->3)Gal-beta1->4Glc-beta1->1'Cer
|
HMDB
|
GalNAc-beta1->4(NeuAc-alpha2->8NeuAc2->3)LacCer
|
HMDB
|
GD2 Ganglioside
|
HMDB
|
65988-71-8
|
CAS Registry Number
|
KEGG COMPOUND
|
3300782
|
PubMed citation
|
Europe PMC
|
9417295
|
PubMed citation
|
Europe PMC
|
|